Zacharon Pharmaceuticals
Latest round
- Series A
Last raised
- Nov 2008
Total raised
- $3.5M
Investors
- 1
About Zacharon Pharmaceuticals
Zacharon Pharmaceuticals Inc.Zacharon Pharmaceuticals Inc. specializes in glycan-targeted therapeutics. Founded in 2004 in San Diego, US, the company was acquired by BioMarin Pharmaceutical Inc. in January 2012 for USD 10 mn, with potential additional milestone payments.Zacharon Pharmaceuticals develops glycan-based therapeutics, concentrating on small molecule drugs targeting glycans, essential components of biological molecules. Their drug discovery platform addresses unmet medical needs in various conditions, partnering with organizations like Acorda Therapeutics and Pfizer.Zacharon Pharmaceuticals generates revenue primarily through B2B partnerships and collaborations, structuring agreements that include milestone payments and royalties based on product success.The company is expected to leverage its recent acquisition by BioMarin Pharmaceutical Inc. to advance its products targeting lysosomal storage diseases and rare cancers. Future plans involve expanding into new geographic regions, particularly targeting North America and Europe, while continuing to build strategic partnerships to enhance its product pipeline.
Who invested in Zacharon Pharmaceuticals
1 investor across 1 round
See all investors in Zacharon Pharmaceuticals
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series A
Nov 18, 2008
Amount
$3.5M
Investors
Questions about Zacharon Pharmaceuticals
Who invested in Zacharon Pharmaceuticals?
Zacharon Pharmaceuticals has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Zacharon Pharmaceuticals raised?
Zacharon Pharmaceuticals has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did Zacharon Pharmaceuticals last raise money?
Zacharon Pharmaceuticals's most recent round on record is a Series A, in Nov 2008.
What does Zacharon Pharmaceuticals do?
Zacharon Pharmaceuticals is a biotechnology company.
Where is Zacharon Pharmaceuticals headquartered?
Zacharon Pharmaceuticals is headquartered in San Diego, US.
Which VCs invest in companies like Zacharon Pharmaceuticals?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at Zacharon Pharmaceuticals's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like Zacharon Pharmaceuticals? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.